WhiteSwell Logo

WhiteSwell Announces $30 Million Financing for New Therapeutic Approach to Acute Decompensated Heart Failure

Funds Will Support Product Development and Clinical Studies of Novel Catheter-Based Technology

WhiteSwell Logo

WhiteSwell Strengthens Patent Portfolio for Treatment of Acute Decompensated Heart
Failure with Newly Issued U.S. Patent

Adds to Portfolio of 40 Patents for Catheter-Based Technology That Leverages Power of Body’s
Natural Fluid Removal Process